Results unveiled at IDWeek 2021 disprove any misconceptions about pediatric COVID-19 cases lacking severity.
Data unveiled this week at the virtual IDWeek 2021 conference shed yet more doubt on the theory that children 18 years of age and younger suffer only mild to asymptomatic symptoms from COVID-19.
That study comes on the heels of a huge randomized controlled peer reviewed study published this week in PLOS Medicine that garnered headlines because not only did it show that 1 in 3 survivors of the disease will exhibit symptoms 3 to 6 months after initial infection, but that younger people also show symptoms. In that study, investigators with Oxford University wrote that “it is notable that long-COVID features were also recorded in children and young adults, and in more than half of non-hospitalized patients, confirming that they occur even in young people and those who had a relatively mild illness….
At the IDWeek conference, it was reported that the emergence of the more infectious Delta variant (B.1.617.2) as the dominant strain in Arkansas led the Arkansas Department of Health (ADH) to investigate whether this is still the case.
Delta did not become the leading variant in Arkansas until the first week in July 2021, but children were contracting COVID-19 at schools during the January 2021 surge even with physical mitigation measures (PMM).
ADH’s findings, presented at the virtual IDWeek conference, showed that there were 31.6% fewer pediatric COVID-19 cases in July 2021 than in January 2021 (8031 versus 11735), but pediatric hospitalization, ICU admission, mechanical ventilation, and death all peaked in July 2021.
Among children infected with the Delta variant, hospitalization was up by 41.9% (n=105), ICU admissions increased 68.6% (n=18), and ventilator use raised by 300% (n=8).
The one pediatric death recorded was the first in Arkansas since the start of the COVID-19 pandemic.
The results disproved any misconceptions about pediatric COVID-19 cases lacking severity. The ADH predicted that the July 2021 Delta outbreak would only result in more pediatric cases as schools opened in the fall, leading them to recommend schools update and reinstate their PMM efforts.
This article originally appeared in Contagion®.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.